» Articles » PMID: 17082606

The Study of High-affinity TCRs Reveals Duality in T Cell Recognition of Antigen: Specificity and Degeneracy

Overview
Journal J Immunol
Date 2006 Nov 4
PMID 17082606
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

TCRs exhibit a high degree of Ag specificity, even though their affinity for the peptide/MHC ligand is in the micromolar range. To explore how Ag specificity is achieved, we studied murine T cells expressing high-affinity TCRs engineered by in vitro evolution for binding to hemoglobin peptide/class II complex (Hb/I-Ek). These TCRs were shown previously to maintain Ag specificity, despite having up to 800-fold higher affinity. We compared the response of the high-affinity TCRs and the low-affinity 3.L2 TCR toward a comprehensive set of peptides containing single substitutions at each TCR contact residue. This specificity analysis revealed that the increase in affinity resulted in a dramatic increase in the number of stimulatory peptides. The apparent discrepancy between observed degeneracy in the recognition of single amino acid-substituted Hb peptides and overall Ag specificity of the high-affinity TCRs was examined by generating chimeric peptides between the stimulatory Hb and nonstimulatory moth cytochrome c peptides. These experiments showed that MHC anchor residues significantly affected TCR recognition of peptide. The high-affinity TCRs allowed us to estimate the affinity, in the millimolar range, of immunologically relevant interactions of the TCR with peptide/MHC ligands that were previously unmeasurable because of their weak nature. Thus, through the study of high-affinity TCRs, we demonstrated that a TCR is more tolerant of single TCR contact residue substitutions than other peptide changes, revealing that recognition of Ag by T cells can exhibit both specificity and degeneracy.

Citing Articles

A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models.

Haque A, Trager N, Butler J, Das A, Zaman V, Banik N Neurochem Int. 2024; 175:105697.

PMID: 38364938 PMC: 10994736. DOI: 10.1016/j.neuint.2024.105697.


Identification of T cell antigens in the 21st century, as difficult as ever.

Lantz O, Teyton L Semin Immunol. 2022; 60:101659.

PMID: 36183497 PMC: 10332289. DOI: 10.1016/j.smim.2022.101659.


SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World's Population.

Patarroyo M, Patarroyo M, Pabon L, Alba M, Bermudez A, Rugeles M Front Immunol. 2022; 13:859905.

PMID: 35693819 PMC: 9175637. DOI: 10.3389/fimmu.2022.859905.


The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Monkeys for Human Use.

Patarroyo M, Patarroyo M, Alba M, Pabon L, Rugeles M, Aguilar-Jimenez W Front Immunol. 2021; 12:724060.

PMID: 34539660 PMC: 8446425. DOI: 10.3389/fimmu.2021.724060.


Potentiating the Antitumor Activity of Cytotoxic T Cells the Transmembrane Domain of IGSF4 That Increases TCR Avidity.

Kim H, Park J, Fatima Y, Kausar M, Park J, Jun C Front Immunol. 2021; 11:591054.

PMID: 33597944 PMC: 7882689. DOI: 10.3389/fimmu.2020.591054.